Cargando…

Interleukin-17: A Promoter in Colorectal Cancer Progression

It is widely accepted that chronic inflammation plays an active role in cancer. Inflammatory immunocytes and related cytokines in the tumor microenvironment are supposed to be a “double-edged sword” in colorectal cancer (CRC) initiation and progression. Interleukin-17 (IL-17), a pleiotropic proinfla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Dang, Wu, Pin, Huang, Qi, Liu, Yang, Ye, Jun, Huang, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870650/ https://www.ncbi.nlm.nih.gov/pubmed/24382972 http://dx.doi.org/10.1155/2013/436307

Ejemplares similares

The Role of Interleukin-17 in Lung Cancer
por: Wu, Feng, et al.
Publicado: (2016)

Interleukin-17 promotes the development of cisplatin resistance in colorectal cancer
por: Sui, Guolong, et al.
Publicado: (2019)

Prognostic Value, Clinicopathologic Features and Diagnostic Accuracy of Interleukin-8 in Colorectal Cancer: A Meta-Analysis
por: Xia, Wenjie, et al.
Publicado: (2015)

Interleukin-17 Could Promote Breast Cancer Progression at Several Stages of the Disease
por: Welte, Thomas, et al.
Publicado: (2015)

Prognostic and clinicopathological significance of serum interleukin-6 expression in colorectal cancer: a systematic review and meta-analysis
por: Wang, Zhen, et al.
Publicado: (2015)

β-catenin Overexpression in the Nucleus Predicts Progress Disease and Unfavourable Survival in Colorectal Cancer: A Meta-Analysis
por: Chen, Zhigang, et al.
Publicado: (2013)

The role of interleukin-17 in tumor development and progression
por: Zhao, Junjie, et al.
Publicado: (2019)

miRNA-27b Targets Vascular Endothelial Growth Factor C to Inhibit Tumor Progression and Angiogenesis in Colorectal Cancer
por: Ye, Jun, et al.
Publicado: (2013)

The Role of Interleukins in Colorectal Cancer
por: Li, Jingjing, et al.
Publicado: (2020)

MicroRNA-141 inhibits tumor growth and minimizes therapy resistance in colorectal cancer
por: Ye, Jun, et al.
Publicado: (2017)

Interleukin-17 Inhibitors for the Treatment of Ankylosing Spondylitis
por: Huang, Jin-Xian, et al.
Publicado: (2020)

Interleukins (Cytokines) as Biomarkers in Colorectal Cancer: Progression, Detection, and Monitoring
por: Maryam, Sajida, et al.
Publicado: (2023)

Interleukin-17 family members in health and disease
por: Chung, Soo-Hyun, et al.
Publicado: (2021)

Targeting interleukin-17 receptors
por: Lee, Wen-Hwa, et al.
Publicado: (2015)

Prognostic Value and Clinicopathological Differences of HIFs in Colorectal Cancer: Evidence from Meta-Analysis
por: Chen, Zhigang, et al.
Publicado: (2013)

Butyrate inhibits interleukin-17 and generates Tregs to ameliorate colorectal colitis in rats
por: Zhang, Mingming, et al.
Publicado: (2016)

E3 Ubiquitin Ligase ASB17 Promotes Apoptosis by Ubiquitylating and Degrading BCLW and MCL1
por: Yang, Ge, et al.
Publicado: (2021)

GNG4 Promotes Tumor Progression in Colorectal Cancer
por: Liang, Liang, et al.
Publicado: (2021)

Interleukin 17A promotes diabetic kidney injury
por: Ma, Jin, et al.
Publicado: (2019)

Interleukin-17 and Interleukin-10 Association with Disease Progression in Schizophrenia
por: Chenniappan, Raghavi, et al.
Publicado: (2020)

Increased Circulatory Interleukin-17A Levels in Patients with Progressive and Leukotrichial Vitiligo
por: Le, Thai Van Thanh, et al.
Publicado: (2021)

Tumor-Associated Neutrophils in Colorectal Cancer Development, Progression and Immunotherapy
por: Zheng, Wei, et al.
Publicado: (2022)

Interleukin-17 and type 17 helper T cells in cancer management and research
por: Llosa, Nicolas J, et al.
Publicado: (2014)

The Interleukin-17 Family of Cytokines in Breast Cancer
por: Fabre, Joseph Antoine Salvator, et al.
Publicado: (2018)

Diagnostic and Prognostic Value of Serum Interleukin-6 in Colorectal Cancer
por: Xu, Jinming, et al.
Publicado: (2016)

γδ T Cells: Crosstalk Between Microbiota, Chronic Inflammation, and Colorectal Cancer
por: Yang, Yunben, et al.
Publicado: (2018)

Interleukin-17A mRNA Expression is Associated with the Prognosis of Patients with Colorectal Cancer: A Pooled Meta-Analysis
por: Yang, Wei, et al.
Publicado: (2022)

Interleukin-17D promotes lung cancer progression by inducing tumor-associated macrophage infiltration via the p38 MAPK signaling pathway
por: Lin, Zhenzhen, et al.
Publicado: (2022)

Interleukin-17 in Antifungal Immunity
por: Sparber, Florian, et al.
Publicado: (2019)

Pretreatment serum interleukin‐1β, interleukin‐6, and tumor necrosis factor‐α levels predict the progression of colorectal cancer
por: Chang, Pei‐Hung, et al.
Publicado: (2016)

Research progress of interleukin-15 in cancer immunotherapy
por: Cai, Menghan, et al.
Publicado: (2023)

Targeting the interleukin-17 immune axis for cancer immunotherapy
por: Vitiello, Gerardo A., et al.
Publicado: (2020)

Interleukin-17 Family Cytokines in Metabolic Disorders and Cancer
por: Meehan, Eileen Victoria, et al.
Publicado: (2022)

Faecalibacterium prausnitzii Inhibits Interleukin-17 to Ameliorate Colorectal Colitis in Rats
por: Zhang, Mingming, et al.
Publicado: (2014)

Interleukin-17A and Keratinocytes in Psoriasis
por: Furue, Masutaka, et al.
Publicado: (2020)

Roles of interleukin-17 in uveitis
por: Guedes, Marta Catarina Esteves, et al.
Publicado: (2016)

The changes of Th17 cells and the related cytokines in the progression of human colorectal cancers
por: Wang, Jiansheng, et al.
Publicado: (2012)

Interleukin-1-Interleukin-17 Signaling Axis Induces Cartilage Destruction and Promotes Experimental Osteoarthritis
por: Na, Hyun Sik, et al.
Publicado: (2020)

Potential Impacts of Interleukin-17A Promoter Polymorphisms on the EGFR Mutation Status and Progression of Non-Small Cell Lung Cancer in Taiwan
por: Lee, Kai-Ling, et al.
Publicado: (2021)

Targeting of interleukin-17 in the treatment of psoriasis
por: Lønnberg, Ann Sophie, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_278p6k90rjv3hqmu5k66l52188